← Back to Clinical Trials
Recruiting Phase 4 NCT06798571

Role of Menopause in Thermoregulation

Trial Parameters

Condition Menopause
Sponsor Penn State University
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 24
Sex FEMALE
Min Age 42 Years
Max Age 64 Years
Start Date 2025-03-01
Completion 2026-03-01
All Conditions
Interventions
Elagolix Oral TabletEstradiol patchcellulose placebo

Brief Summary

The frequency and severity of heat waves has increased in the last decades. Older adults (over 65 years) have impaired responses to heat stress making them at increased risk for adverse events. Previous heat waves report that women over 65 experience worse health outcomes than any other age group and age matched men. Aging and reproductive hormones, specifically estrogen, independently alter responses to heat stress. However, the combined effects of low estrogen following menopause and aging on the response to heat stress are unknown. In this study, the investigators will identify the role of estrogen in pre and post menopausal women on thermoregulatory responses to heat stress.

Eligibility Criteria

Inclusion Criteria: * Women ages 42-64 Exclusion Criteria: * Chron's disease, diverticulitis, or similar gastrointestinal disease * Abnormal resting exercise electrocardiogram (ECG) * Tobacco use * High-risk determined by the Atherosclerotic Cardiovascular Disease (CVD) Risk Factor * Assessment * Using hormone therapy * Using hormonal contraceptives

Related Trials